How have COCP and INAB total returns compared?

Over the past 5 years, COCP delivered -37.50% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.

Cocrystal Pharma, Inc. (COCP) vs IN8bio, Inc. (INAB)

A side-by-side comparison of Cocrystal Pharma, Inc. and IN8bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COCP

Cocrystal Pharma, Inc.

$15M

$1.11HealthcareDelayed quote: Oct 6, 2026, 2:51 PM EDT

INAB

IN8bio, Inc.

$13M

$1.39HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT

Total return — COCP vs INAB

growth of $100 · dividends reinvested · last 5y

COCP -91.6% (-39.1%/yr)INAB -99.5% (-65.7%/yr)COCP compounded faster over this window

Log scale — wide-divergence pair

COCP INAB

COCP vs INAB: by the numbers

•COCP is the larger company ($15M vs $13M market cap).
•Both run net losses; INAB's is the smaller (0.00% vs -3011.52% net margin).

Metrics side by side

Valuation

Metric	COCP	INAB
P/S ratio	46.17	N/A
P/B ratio	14.59	0.73

Profitability

Metric	COCP	INAB
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	-3011.52%	0.00%
ROE	-951.92%	-101.66%
ROIC	-497.29%	-91.74%

Growth (annualized)

Metric	COCP	INAB
Revenue CAGR (5Y)	91.55%	N/A
Total return CAGR (5Y)	-37.50%	-62.88%

Frequently asked

How have COCP and INAB total returns compared?: Over the past 5 years, COCP delivered -37.50% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COCP analysis Full INAB analysis Interactive comparison tool

Dig into the metrics

Cocrystal Pharma ROE IN8bio ROE Cocrystal Pharma operating margin IN8bio operating margin Cocrystal Pharma revenue growth IN8bio revenue growth Cocrystal Pharma free cash flow IN8bio free cash flow

Cocrystal Pharma & IN8bio appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.